Literature DB >> 8449086

Efficacy of 1.4 percent sodium citrate in maintaining arterial catheter patency in patients in a medical ICU.

P K Branson1, R A McCoy, B A Phillips, G D Clifton.   

Abstract

PURPOSE: The primary purpose of this study was to compare the efficacy of 1.4 percent sodium citrate with heparin, 4 U/ml, for maintaining radial artery catheter patency in patients in the medical ICU. PATIENTS AND METHODS: Patients in the medical ICU (n = 40) were randomized to either a 1.4 percent sodium citrate or heparin 4 U/ml arterial line flush solution in a double-blind, parallel fashion. The flush solutions were continuously infused at approximately 3 ml/h over a maximum of 96 h. Catheter survival rates were compared using Kaplan-Meier survival curves. The frequency of catheter malfunctions and corrective manipulations were recorded and compared. Coagulation status (APTT, PT) and ionized calcium values were monitored to evaluate the systemic effects of sodium citrate.
RESULTS: Ninety-four percent of catheters flushed with sodium citrate were functional at 48 h compared with 88 percent for heparin (p > 0.05). At 96 h, 80 percent vs 88 percent of the catheters were functional in the citrate and heparin groups, respectively (p > 0.05). Frequency of catheter malfunctions did not differ between the two groups. No systemic effects of sodium citrate were observed.
CONCLUSION: Arterial catheter flush solutions containing sodium citrate (1.4 percent) are an effective and safe alternative to heparin in patients requiring peripheral arterial catheterization.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449086     DOI: 10.1378/chest.103.3.882

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials.

Authors:  A G Randolph; D J Cook; C A Gonzales; M Andrew
Journal:  BMJ       Date:  1998-03-28

2.  Antimicrobial activity of a novel catheter lock solution.

Authors:  Chirag B Shah; Marc W Mittelman; J W Costerton; Stephen Parenteau; Michael Pelak; Richard Arsenault; Leonard A Mermel
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 3.  Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

Authors:  Eduardo López-Briz; Vicente Ruiz Garcia; Juan B Cabello; Sylvia Bort-Martí; Rafael Carbonell Sanchis
Journal:  Cochrane Database Syst Rev       Date:  2022-07-18

Review 4.  Heparin versus normal saline for patency of arterial lines.

Authors:  Suzanne Robertson-Malt; Greg N Malt; Vincent Farquhar; William Greer
Journal:  Cochrane Database Syst Rev       Date:  2014-05-13

Review 5.  Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

Authors:  Eduardo López-Briz; Vicente Ruiz Garcia; Juan B Cabello; Sylvia Bort-Martí; Rafael Carbonell Sanchis; Amanda Burls
Journal:  Cochrane Database Syst Rev       Date:  2018-07-30

6.  Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens).

Authors:  Janusz Steczko; Stephen R Ash; David E Nivens; Lloyd Brewer; Roland K Winger
Journal:  Nephrol Dial Transplant       Date:  2009-01-30       Impact factor: 5.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.